Related Experiment Video
Updated: Jun 13, 2026
06:12
Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
Published on: January 27, 2022
Systemic transplantation of embryonic stem cells accelerates brain lesion decrease and angiogenesis
Nobuo Nagai1, Naoyuki Kawao, Kiyotaka Okada
1Department of Physiology, Kinki University School of Medicine, Osaka, Japan.
Neuroreport
|May 1, 2010
Summary
Embryonic stem cell transplantation may reduce brain damage by promoting new blood vessel growth. This study found smaller lesions and increased microvessels in treated mice, suggesting enhanced angiogenesis.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Stem cells offer therapeutic potential for tissue regeneration, including brain damage.
- Investigating the efficacy of stem cell transplantation in neurological injury models is crucial.
Purpose of the Study:
- To evaluate the therapeutic effects of embryonic stem cell transplantation on brain damage.
- To elucidate the underlying mechanisms of stem cell-mediated repair in a brain injury model.
Main Methods:
- A photochemically induced thrombotic brain damage model was utilized in mice.
- Systemic transplantation of enhanced green fluorescence protein (EGFP)-expressing embryonic stem cells was performed.
- Brain lesion size and microvessel density were assessed at specific time points.
Main Results:
- Embryonic stem cell transplantation resulted in significantly smaller brain lesion sizes compared to controls.
- An increase in microvessel density was observed at the border of the damaged area.
- No EGFP-positive cells were detected within or around the lesion site, indicating no cell engraftment.
Conclusions:
- Embryonic stem cell transplantation effectively reduced brain lesion size.
- The therapeutic effect is likely mediated by the acceleration of angiogenesis via endogenous endothelial cells, not direct cell replacement.
- These findings highlight a novel mechanism for stem cell therapy in brain injury.
